Valuation: Cipla Limited

Market Cap 1,051B 10.86B 9.7B 9.02B 8.21B 15.5B 15.56B 109B 42.55B 536B 40.78B 39.89B 1,720B P/E 2027 *
25.4x
P/E 2028 * 20.4x
Enterprise Value 945B 9.76B 8.72B 8.11B 7.38B 13.93B 13.99B 97.63B 38.25B 482B 36.66B 35.86B 1,546B EV / Sales 2027 *
3.06x
EV / Sales 2028 * 2.65x
Free-Float
68.87%
Yield 2027 *
1%
Yield 2028 * 1.13%
1 day-0.44%
1 week-3.20%
Current month-3.34%
1 month-4.56%
3 months-9.73%
6 months+6.26%
Current year-13.92%
1 week 1,292
Extreme 1292
1,351
1 month 1,292
Extreme 1292
1,421
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
Director of Finance/CFO - 24/07/2026
President - 18/05/2026
Director TitleAgeSince
Chairman 90 21/07/1972
Director/Board Member 72 25/07/2014
Director/Board Member 71 30/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
22/8/24 Sell 2,000 0.0002%
14/8/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.44%-3.20%-14.02%+12.20% 10.86B
+0.83%+3.19%+37.87%+106.25% 1,051B
+1.93%+2.11%+36.82%+64.90% 630B
+1.49%+5.19%+19.84%+85.41% 489B
+2.26%+0.90%+66.40%+39.33% 359B
+1.45%+3.50%+21.87%+42.64% 344B
+1.17%+2.37%+11.71%+35.14% 272B
+0.89%+1.08%-7.28%+10.52% 246B
+1.82%+2.94%+40.43%+52.78% 224B
+2.77%+4.44%+29.49%+101.40% 187B
Average +1.30%+1.96%+24.31%+55.06% 381.46B
Weighted average by Cap. +1.19%+2.43%+31.44%+69.80%

Financials

2027 *2028 *
Net sales 309B 3.2B 2.85B 2.66B 2.42B 4.56B 4.58B 31.96B 12.52B 158B 12B 11.74B 506B 347B 3.58B 3.2B 2.98B 2.71B 5.11B 5.14B 35.83B 14.04B 177B 13.46B 13.16B 567B
Net income 41.18B 426M 380M 354M 322M 607M 610M 4.25B 1.67B 21B 1.6B 1.56B 67.38B 51.49B 532M 475M 442M 402M 759M 762M 5.32B 2.08B 26.25B 2B 1.95B 84.24B
Net Debt -106B -1.1B -979M -911M -828M -1.56B -1.57B -10.96B -4.3B -54.09B -4.12B -4.03B -174B -131B -1.36B -1.21B -1.13B -1.03B -1.94B -1.95B -13.58B -5.32B -67.02B -5.1B -4.99B -215B
Projected Income Statement - Annual - Cipla Limited
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
09/10/26 ₹1,301.00 -0.44% 653,621
08/10/26 ₹1,306.80 -1.54% 551,708
07/10/26 ₹1,327.20 -0.97% 847,901
06/10/26 ₹1,340.20 +0.35% 575,696
05/10/26 ₹1,335.50 -0.63% 1,084,209
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Cipla Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,301.00INR
Average target price
1,512.19INR
Spread / Average Target
+16.23%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cipla Limited
  1. Stock Market
  2. Stocks
  3. CIPLA Stock